4.8 Article

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

Journal

NUCLEIC ACIDS RESEARCH
Volume 46, Issue D1, Pages D1091-D1106

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkx1121

Keywords

-

Funding

  1. IUPHAR
  2. BPS [MED791]
  3. Wellcome Trust [108420/Z/15/Z]
  4. American Society for Pharmacology and Experimental Therapeutics
  5. Laboratoires Servier
  6. University of Edinburgh
  7. Wellcome Trust

Ask authors/readers for more resources

The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). As previously described, our unique model of content selection and quality control is based on 96 targetclass subcommittees comprising 512 scientists collaborating with in-house curators. This update describes content expansion, new features and interoperability improvements introduced in the 10 releases since August 2015. Our relationship matrix now describes similar to 9000 ligands, similar to 15 000 binding constants, similar to 6000 papers and similar to 1700 human proteins. As an important addition, we also introduce our newly funded project for the Guide to IMMUNOPHARMACOLOGY (GtoImmuPdb,www.guidetoimmunopharmacology.org). This has been 'forked' fromthe well-established GtoPdb data model and expanded into new types of data related to the immune system and inflammatory processes. This includes new ligands, targets, pathways, cell types and diseases forwhich we are recruiting newIUPHAR expert committees. Designed as an immunopharmacological gateway, it also has an emphasis on potential therapeutic interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available